Advantages of Proactive Therapeutic Drug Monitoring in a Prospective Cohort of Children With Inflammatory Bowel Disease Treated With Anti-Tumour Necrosis Factor-论文-万方医学网

首页> > Advantages of Proactive Therapeutic Drug Monitoring in a Prospective Cohort of Children With Inflammatory Bowel Disease Treated With Anti-Tumour Necrosis Factor

Advantages of Proactive Therapeutic Drug Monitoring in a Prospective Cohort of Children With Inflammatory Bowel Disease Treated With Anti-Tumour Necrosis Factor

导出原文传递

翻译打印收藏纠错

第一作者： Marco,Gasparetto

作者： Marco,Gasparetto ^[1] ; Natasha,Burgess ^[2] ; Sandhia,Naik ; Dominic,Studart ; Ahmed,Kadir ; Nick,Croft ; Ian,Sanderson ; Protima,Deb

作者单位： Department of Paediatric Gastroenterology, The Royal London Children's Hospital, Barts Health NHS ^[1] Blizard Institute, Barts and the London, Queen Mary University London, London, UK. ^[2]

发布时间 2022-07-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Advantages of Proactive Therapeutic Drug Monitoring in a Prospective Cohort of Children With Inflammatory Bowel Disease Treated With Anti-Tumour Necrosis Factor

相似文献

同项目论文

相关期刊

检索历史 清除

Advantages of Proactive Therapeutic Drug Monitoring in a Prospective Cohort of Children With Inflammatory Bowel Disease Treated With Anti-Tumour Necrosis Factor

相似文献

同项目论文

相关期刊

检索历史清除